The short version of LC-MS/MS fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-06-17. Anything still debated is marked as such rather than presented as settled.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
Laboratory studies have examined GW501516 in cell cultures and rodents for conditions such as dyslipidemia, insulin resistance, and obesity. Some trials in humans were initiated, but development was discontinued after preclinical findings raised concerns about cancer in certain models. Those findings do not prove that the compound causes cancer in people, but they contributed to regulatory caution. Later reviews often describe the evidence as preliminary and insufficient for assessing long-term safety.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | GW501516, GW-501516, GW 501516, endurobol | Names vary in research and anti-doping documents. |
| Chemical class | Synthetic PPARδ agonist | Small-molecule nuclear receptor ligand. |
| CAS Registry Number | 317318-70-0 | Identifier commonly associated with GW501516. |
| Appearance | White to off-white powder | Typical for purified research material. |
| Solubility | Low in water; soluble in DMSO and ethanol | Organic solvents are common for laboratory stock solutions. |
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
=== Home media === The film was released by The Criterion Collection as a Region 1 DVD on 25 November 2008 and on Blu-ray on 10 September 2013. Extras for this version include: digitally restored picture and sound; an interview with John le Carré; scene-specific commentary by director of photography Oswald Morris; a BBC documentary titled The Secret Centre: John le Carré (2000); an interview with Richard Burton from a 1967 episode of the BBC series Acting in the '60s; a 1985 audio interview with director Martin Ritt; a gallery of set designs; the film's theatrical trailer; and a booklet featuring an essay by film critic Michael Sragow.
==== Transportation of RNP and viral proteins to cellular membrane ==== After translation, SeV nucleocapsids (RNP complex) assemble, and move using microtubules network through intracellular vesicular trafficking pathway. In preparation for the budding process, three viral lipophilic proteins HN, F and M migrate through the secretory pathway to a host cell membrane. It is assumed that the interaction of these three proteins with each other is needed for their migration to cellular budding sites. The binding of lipophilic protein complex to the host membrane facilitates the interaction of this three protein complex with the SeV nucleocapsid. It has been shown that for efficient virion production SeV induces the β-cytoplasmic actin remodeling in its host cell.
==== Approved topical medicine ==== In the European Union, a prescription gel containing birch bark extract (commercial name Episalvan, betulae cortex dry extract (5–10 : 1); extraction solvent: n-heptane 95% (w/w)) was approved in 2016 for the topical treatment of minor skin wounds in adults. Although its mechanism of action in helping to heal injured skin is not fully understood, birch bark extract appears to stimulate the growth of keratinocytes which then fill the wound.
== Transfer of pathogens by fomites == A fomite is any inanimate object (also called passive vector) that, when contaminated with or exposed to infectious agents (such as pathogenic bacteria, viruses or fungi), can transfer disease to a new host. Contamination can occur when one of these objects comes into contact with bodily secretions, like nasal fluid, vomit or feces from toilet plume. Many common objects can sustain a pathogen until a person comes in contact with the pathogen, increasing the chance of infection. The likely objects are different in a hospital environment than at home or in a workplace. Fomites such as splinters, barbed wire or farmyard surfaces, including soil, feeding troughs or barn beams, have been implicated as sources of virus.
Sources: en.wikipedia.org
In organic chemistry, a carbamate is a category of organic compounds with the general formula R2NC(O)OR and structure >N−C(=O)−O−, which are formally derived from carbamic acid (NH2COOH). The term includes organic compounds (e.g., the ester ethyl carbamate), formally obtained by replacing one or more of the hydrogen atoms by other organic functional groups; as well as salts with the carbamate anion H2NCOO− (e.g. ammonium carbamate). Polymers whose repeat units are joined by carbamate like groups −NH−C(=O)−O− are an important family of plastics, the polyurethanes.
== Partnerships == Towards fulfilling its mandate, RCB is collaborating with various national and international institutions of repute. The partnerships are meant for exchange of ideas, information sharing, training, networking, conducting scientific colloquia, workshops, academic exchange programmes and student study visits within (and outside) India and for students of the Asia-Pacific region. RCB and National Institute of Advanced Industrial Science and Technology (AIST), Japan announced a partnership to further capacity building initiatives in bio-imaging and biotechnology. The agreement offers an excellent opportunity for both the institutions in capacity building, training and research collaborations, benefitting young scientists not only in India and Japan, but also from the UNESCO member countries in the Asia-Pacific and SAARC regions. In its continuing effort to fulfill the core mandate, RCB is actively engaged in a range of research and related activities in partnership with other academic institutions, which form part of the NCR Biotech Science Cluster, Faridabad. Shared facilities such as Advanced Technology Platform Centre (ATPC), and Bioincubators (supported by Biotechnology Industry Research Assistance Council (BIRAC)), which is meant to support the budding biotechnology entrepreneurs, are being established.
== Measurement techniques == Standard organic geochemical methods are employed to prepare samples of dinosterol for analysis. Collected algae samples can be centrifuged and then lyophilized. A Bligh and Dyer extraction can then be performed to isolate the major lipid classes. Lipid samples are often derivatized with bis(trimethylsilyl)trifluoroacetamide (BSTFA) for gas chromatography-mass spectrometry (GC-MS) analysis.
Lukas May, lately Deputy Director, Comprehensive and Progressive Agreement for Trans-Pacific Partnership, Department for Business and Trade. For services to International Trade. Kyron McMaster, Track and Field Athlete, British Virgin Islands. For services to Sport in the British Virgin Islands. Catherine O'Neill, lately Joint Head, Royal and Coronation Unit, Foreign, Commonwealth and Development Office. For services to British Foreign Policy and to the Coronation of Their Majesties The King and The Queen. Professor Nicholas Paton, Professor of Infectious Diseases, National University of Singapore and the London School of Hygiene and Tropical Medicine. For services to Global Health. Jacqueline Perkins, HM Ambassador, Minsk, Belarus. For services to British Foreign Policy. Ashley Pigott, Chairman and Managing Director, AJ Power, Northern Ireland. For services to UK Exports and Manufacturing. Lawrence Podesta, lately Chief Executive Officer, Gibraltar International Bank Ltd, Gibraltar. For services to Banking in Gibraltar. George Robinson, Deputy Director, Trade and Goods, Windsor Framework Taskforce, Foreign, Commonwealth and Development Office. For services to British Foreign Policy. Taban Shoresh, Genocide Survivor and Founder and Chief Executive Officer, The Lotus Flower. For services to Refugees and Displaced Conflict Survivors in the Kurdistan Region of Iraq. Professor Gareth Stansfield, Pro-Vice-Chancellor and Executive Dean, University of Exeter. For services to UK interests in Iraq. Michael Vidler, Solicitor, lately of Vidlers and Co Solicitors, Hong Kong.
=== Laboratory Analysers === Automated analysers, by the association of robotics and spectrophotometry, have allowed these last decades better reproducibility of the results, in particular in medical biochemistry and hematology. Efficiency and productivity can be enhanced by automating the pre-analytical processing, including barcode reading, sorting, centrifuging, and aliquoting specimens. The analysers must undergo daily controls prior to performing patient testing. Analysers must also undergo daily, weekly and monthly maintenance. Quality management involves reviewing quality control trends to detect emerging problems in instrument calibration, correlating results between instruments that perform similar testing, and running standardized samples to prove linearity and precision. Some laboratory processes involve automated analysis combined with manual review by technologists. For example, when hematology analysers flag samples as abnormal, automated white blood cell differential counts may be superseded by manual differential counts using stained slides read at the microscope or scanned by digital imaging software. Laboratory technologists may flag abnormal samples for pathologist review. The pathologist may recommend additional testing, such as flow cytometry to identify lymphoma or leukemia cells, or cytology to characterize solid tumor cells.
Sources: en.wikipedia.org
== Cleavage & Deprotection == The Fmoc group is rapidly removed by base. Piperidine is usually preferred for Fmoc group removal as it forms a stable adduct with the dibenzofulvene byproduct, preventing it from reacting with the substrate.
In 2024, Dalman and colleagues described the remains of a tyrannosaur discovered in 1983 in the Campanian-early Maastrichtian Hall Lake Formation in New Mexico. Reposited at the New Mexico Museum of Natural History and Science, the fossil material (NMMNH P-3698) consists of the right postorbital, right squamosal, left palatine, and an incomplete maxilla from the skull, the left dentary, right splenial, right prearticular, right angular and right articular from the lower jaws, isolated teeth, and chevrons. Some of the bones were briefly mentioned in 1984 as belonging to T. rex, and described in 1986. Lehman and Carpenter (1990) suggested that NMMNH P-3698 belonged to a new tyrannosaurid genus, while Carr and Williamson (2000) disagreed with their claim. Sullivan and Lucas (2015) argued that there is little evidence to support NMMNH P-3698 as a specimen of Tyrannosaurus rex, so they tentatively classified it as cf. Tyrannosaurus sp.; they also considered that the McRae tyrannosaur lived before the Lancian (before 67 million years ago) based on its probable association with the Alamosaurus fossil.
=== Proliferative phase === In the proliferative phase, immature granulation tissue containing plump, active fibroblasts forms. Fibroblasts quickly produce abundant type III collagen, which fills the defect left by an open wound. Granulation tissue moves, as a wave, from the border of the injury towards the center. As granulation tissue matures, the fibroblasts produce less collagen and become more spindly in appearance. They begin to produce the much stronger type I collagen. Some of the fibroblasts mature into myofibroblasts which contain the same type of actin found in smooth muscle, which enables them to contract and reduce the size of the wound.
From 1995 to 1996, he was the voice of the character Halcyon Renard in the Disney adventure cartoon Gargoyles. Culp also appeared on Walker, Texas Ranger as Lyle Pike in the episode "Trust No One" (1995). From 1996 to 2004, Culp had a recurring role on Everybody Loves Raymond as Warren Whelan, the father of Debra Barone and father-in-law of Ray Barone. He played a CIA agent and the father of Dr. Jesse Travis on Diagnosis: Murder in the episode "Discards" (1997), along with Barbara Bain, Robert Vaughn, and Patrick Macnee. In 2007, he did a voice-over on the stop-motion sketch comedy Robot Chicken.
==== Deka Machines ==== The Deka Machines (デカマシン, Deka Mashin) are vehicle-themed mecha that are dispatched from the Deka Base and can combine into giant robots through either Tokusou Combination (特捜合体, Tokusō Gattai) or Tokusou Transformation (特捜変形, Tokusō Henkei).
Sources: en.wikipedia.org
Cardarine is an investigational synthetic compound that acts as a PPARδ agonist. It is also known as GW501516 and has been studied mainly in preclinical research. It is not an approved medicine.
No. Cardarine is not a steroid hormone; it targets the nuclear receptor PPARδ. Its classification in anti-doping rules differs from anabolic steroids, though it remains prohibited in sport.
Early rodent studies reported tumor formation at multiple sites, which raised safety concerns. Sponsors stopped clinical development, and no approved human product exists.
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.